Personalized medicine aims to tailor treatments based on the individual genetic makeup of a patient. By using Genemania to analyze the gene networks of a patient's tumor, clinicians can identify specific mutations and pathways that are active in that particular cancer. This information can guide the selection of targeted therapies that are more likely to be effective for that patient, thereby increasing the chances of successful treatment.
